Your browser doesn't support javascript.
loading
Is the NefIgArd trial a paradigm shift in the treatment of IgA nephropathy?
Gutiérrez, Eduardo; Caravaca-Fontán, Fernando; Sevillano, Ángel.
Affiliation
  • Gutiérrez E; Nephrology Department, University Hospital "12 de Octubre", Madrid, Spain.
  • Caravaca-Fontán F; Nephrology Department, Research Institute "Hospital 12 de Octubre" (imas12), Madrid, Spain. Electronic address: fcaravacaf@gmail.com.
  • Sevillano Á; Nephrology Department, University Hospital "12 de Octubre", Madrid, Spain.
Kidney Int ; 103(5): 994, 2023 05.
Article in En | MEDLINE | ID: mdl-37085261
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, IGA Limits: Humans Language: En Journal: Kidney Int Year: 2023 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, IGA Limits: Humans Language: En Journal: Kidney Int Year: 2023 Type: Article Affiliation country: Spain